{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:47:33Z","timestamp":1791222453933,"version":"4.1.0"},"reference-count":174,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.clinthera.2007.12.003","type":"journal-article","created":{"date-parts":[[2008,1,7]],"date-time":"2008-01-07T07:17:33Z","timestamp":1199690253000},"page":"2477-2497","source":"Crossref","is-referenced-by-count":137,"special_numbering":"S1","title":["Adverse drug interactions involving common prescription and over-the-counter analgesic agents"],"prefix":"10.1016","volume":"29","author":[{"given":"Elliot V.","family":"Hersh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2007.12.003_bib1","first-page":"34","article-title":"Top 200 prescription drugs of 2006","volume":"73","author":"Lamb","year":"2007","journal-title":"Pharm Times"},{"key":"10.1016\/j.clinthera.2007.12.003_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rdc.2006.12.003","article-title":"New developments in osteoarthritis","volume":"33","author":"Sun","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clinthera.2007.12.003_bib3","first-page":"201","article-title":"Dental therapeutic practice patterns in the US. II. Analgesics, corticosteroids, and antibiotics","volume":"54","author":"Moore","year":"2006","journal-title":"Gen Dent"},{"key":"10.1016\/j.clinthera.2007.12.003_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0149-2918(01)80005-9","article-title":"Efficacy and tolerability of celecoxib versus hydrocodone\/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults","volume":"23","author":"Gimbel","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib5","first-page":"1064","article-title":"Is any one analgesic superior for episodic tension-type headache?","volume":"55","author":"Verhagen","year":"2006","journal-title":"J Fam Pract"},{"key":"10.1016\/j.clinthera.2007.12.003_bib6","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/j.1552-4604.1996.tb04165.x","article-title":"Nonprescription ibuprofen and acetaminophen in the treatment of tension-type headache","volume":"36","author":"Schachtel","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.berh.2005.03.011","article-title":"The use of medication in low back pain","volume":"19","author":"Mens","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib8","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1471-0528.1998.tb10210.x","article-title":"Efficacy of minor analgesics in primary dysmenorrhoea: A systematic review","volume":"105","author":"Zhang","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib9","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.annemergmed.2006.08.030","article-title":"Tramadol\/acetaminophen or hydrocodone\/acetaminophen for the treatment of ankle sprain: A randomized, placebo-controlled trial","volume":"49","author":"Hewitt","year":"2007","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0149-2918(00)80043-0","article-title":"Over-the-counter analgesics and antipyretics: A critical assessment","volume":"22","author":"Hersh","year":"2000","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib11","first-page":"2218","article-title":"Patterns of use and public perception of over-the-counter pain relievers: Focus on nonsteroidal antiinflammatory drugs","volume":"32","author":"Wilcox","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib12","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1016\/S0002-9343(00)00645-8","article-title":"Aspirin: New cardiovascular uses for an old drug","volume":"110","author":"Patrono","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.amjcard.2006.02.018","article-title":"Nonnarcotic analgesics and hypertension","volume":"97","author":"Gaziano","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.amjcard.2006.02.020","article-title":"Potential for drug-drug interactions in patients taking analgesics for mild-to-moderate pain and low-dose aspirin for cardioprotection","volume":"97","author":"Gaziano","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.14219\/jada.archive.1999.0028","article-title":"Adverse drug interactions in dental practice. Professional and educational implications","volume":"130","author":"Moore","year":"1999","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.clinthera.2007.12.003_bib16","first-page":"2088","article-title":"Nonsteroidal therapy of rheumatoid arthritis and osteoarthritis: How physicians manage treatment failures","volume":"25","author":"Spencer-Green","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00044011-200424020-00004","article-title":"Safety and efficacy of oral nonsteroidal anti-inflammatory drugs in patients with rheumatoid arthritis: A six-month randomised study","volume":"24","author":"Shi","year":"2004","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.clinthera.2007.12.003_bib18","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2007.12.003_bib19","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.18553\/jmcp.2003.9.3.223","article-title":"Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain","volume":"9","author":"Ackerman","year":"2003","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.clinthera.2007.12.003_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1090-3801(98)90020-9","article-title":"Controlled-release oxycodone compared with controlled- release morphine in the treatment of cancer pain: A randomized, double-blind, parallel-group study","volume":"2","author":"Mucci-LoRusso","year":"1998","journal-title":"Eur J Pain"},{"key":"10.1016\/j.clinthera.2007.12.003_bib22","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1185\/030079907X199493","article-title":"Pain relief and pain-related sleep disturbance with extended-release tramadol in patients with osteoarthritis","volume":"23","author":"Kosinski","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2007.12.003_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clinthera.2007.01.001","article-title":"A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain","volume":"29","author":"Beaulieu","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib24","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1001\/archinte.164.21.2361","article-title":"Characterizations of long-term oxycodone\/acetaminophen prescriptions in veteran patients","volume":"164","author":"Hermos","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib25","series-title":"Stockley's Drug Interactions","year":"2002"},{"key":"10.1016\/j.clinthera.2007.12.003_bib26","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00007691-200308000-00011","article-title":"A new turbidometric digoxin immunoassay on the ADVIA 1650 analyzer is flee from interference by spironolactone, potassium canrenoate, and their common metabolite canrenone","volume":"25","author":"Datta","year":"2003","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinthera.2007.12.003_bib27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1592\/phco.26.5.619","article-title":"Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients","volume":"26","author":"Raebel","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2007.12.003_bib28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1440-1819.2004.01188.x","article-title":"Implication of serum concentration monitoring in patients with lithium intoxication","volume":"58","author":"Chen","year":"2004","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.clinthera.2007.12.003_bib29","series-title":"A Profile of Older Americans: 2000","author":"Duncker","year":"2000"},{"key":"10.1016\/j.clinthera.2007.12.003_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1532-5415.1988.tb01809.x","article-title":"Prescribing for the elderly: Part II. Prescribing patterns: Differences due to age","volume":"36","author":"Nolan","year":"1988","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2007.12.003_bib31","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.exger.2004.05.011","article-title":"Drug therapy in the elderly","volume":"39","author":"Turnheim","year":"2004","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib32","doi-asserted-by":"crossref","first-page":"298","DOI":"10.14219\/jada.archive.2004.0178","article-title":"Drug interactions in dentistry: The importance of knowing your CYPs","volume":"135","author":"Hersh","year":"2004","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.clinthera.2007.12.003_bib33","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/009127009903900513","article-title":"The safety profile of non-prescription ibuprofen in multiple-dose use: A meta-analysis","volume":"39","author":"Kellstein","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib34","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0149-2918(95)80036-0","article-title":"Safety profile of over-the-counter naproxen sodium","volume":"17","author":"DeArmond","year":"1995","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib35","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/bmj.312.7046.1563","article-title":"Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysis","volume":"312","author":"Henry","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2007.12.003_bib36","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1365-2125.2002.01636.x","article-title":"Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: A meta-analysis based on individual patient data","volume":"54","author":"Lewis","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib37","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1053\/j.gastro.2005.08.051","article-title":"Risk of serious upper gastro-intestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs","volume":"129","author":"Lewis","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2007.12.003_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1081\/CLT-120002882","article-title":"Acetaminophen hepatotoxicity: The first 35 years","volume":"40","author":"Rumack","year":"2002","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/lt.500050102","article-title":"Etiology and outcome for 295 patients with acute liver failure in the United States","volume":"5","author":"Schiodt","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.clinthera.2007.12.003_bib40","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/cpt1974154368","article-title":"Effects of diazepam and codeine, alone and in combination with alcohol, on simulated driving","volume":"15","author":"Linnoila","year":"1974","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib41","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0773.1989.tb01168.x","article-title":"Psychomotor, respiratory and neuroendocrinological effects of a mu-opioid receptor agonist (oxycodone) in healthy volunteers","volume":"65","author":"Saarialho-Kere","year":"1989","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1520\/JFS2002323","article-title":"A fatal drug interaction between oxycodone and clonazepam","volume":"48","author":"Burrows","year":"2003","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.clinthera.2007.12.003_bib43","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/01.ftd.0000179853.16846.a9","article-title":"Recent trends in narcotic deaths","volume":"27","author":"Drummer","year":"2005","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinthera.2007.12.003_bib44","first-page":"183","article-title":"Acute codeine overdose: Correspondence between clinical course and codeine metabolism","volume":"136","author":"Huffman","year":"1975","journal-title":"Johns Hopkins Med J"},{"key":"10.1016\/j.clinthera.2007.12.003_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003088-198207020-00001","article-title":"Clinical pharmacokinetics of paracetamol","volume":"7","author":"Forrest","year":"1982","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2007.12.003_bib46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0009-9236(96)90050-8","article-title":"The complex interaction between ethanol and acetaminophen","volume":"60","author":"Slattery","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib47","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(83)92150-5","article-title":"Is there a place for cimetidine or ethanol in the treatment of paracetamol poisoning?","volume":"1","author":"Critchley","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2007.12.003_bib48","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archinte.141.3.380","article-title":"Acetaminophen overdose. 662 Cases with evaluation of oral acetylcysteine treatment","volume":"141","author":"Rumack","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib49","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1067\/mcp.2000.106574","article-title":"Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults","volume":"67","author":"Thummel","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0733-8627(20)30837-3","article-title":"Acetaminophen overdose","volume":"2","author":"Linden","year":"1984","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.clinthera.2007.12.003_bib51","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/gut.29.9.1153","article-title":"Glutathione deficiency in alcoholics: Risk factor for paracetamol hepatotoxicity","volume":"29","author":"Lauterburg","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2007.12.003_bib52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00045391-200007020-00009","article-title":"Treatment of pain or fever with paracetamol (acetaminophen) in the alcoholic patient: A systematic review","volume":"7","author":"Dart","year":"2000","journal-title":"Am J Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1741-7015-5-13","article-title":"The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients-a multicenter randomized study","volume":"5","author":"Kuffner","year":"2007","journal-title":"BMC Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib54","first-page":"56789","article-title":"Over-the-counter drug products containing analgesic\/antipyretic active ingredients for internal use. Required alcohol warning","volume":"63","year":"1998","journal-title":"Fed Reglst"},{"key":"10.1016\/j.clinthera.2007.12.003_bib55","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1185\/030079905X56367","article-title":"Update of cyclooxygenase inhibitors: Has a third COX isoform entered the fray?","volume":"21","author":"Hersh","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2007.12.003_bib56","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM198411083111902","article-title":"Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase","volume":"311","author":"Pedersen","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib57","first-page":"15","article-title":"COX-1 and COX-2 tissue expression: Implications and predictions","volume":"49","author":"Crofford","year":"1997","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.clinthera.2007.12.003_bib58","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/rheumatology\/41.4.458","article-title":"Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygen ase-2-selective inhibitots in patients with rheumatoid arthritis","volume":"41","author":"Knijff-Dutmer","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clinthera.2007.12.003_bib59","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa050493","article-title":"Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial","volume":"352","author":"Bresalier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib60","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa050330","article-title":"Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery","volume":"352","author":"Nussmeier","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib61_1","unstructured":"FDA news: FDA announces series of changes to the class of marketed non-steroidal anti-inflammatory drugs (NSAIDs) [FDA Web site]"},{"key":"10.1016\/j.clinthera.2007.12.003_bib62","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa050405","article-title":"Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention","volume":"352","author":"Solomon","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib63_1","unstructured":"Jenkins JK, Seligman PJ. Analysis and recommendations for agency action regarding non-steroidal anti-inflammatory drugs and cardiovascular risk [FDA Web site]"},{"key":"10.1016\/j.clinthera.2007.12.003_bib64","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s10620-006-9229-7","article-title":"Canonical correlation analysis of factors involved in the occurrence of peptic ulcers","volume":"52","author":"Bawurt","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinthera.2007.12.003_bib65","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/bmj.4.5632.664","article-title":"Alcohol, aspirin, and gastrointestinal bleeding","volume":"4","author":"Goulston","year":"1968","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2007.12.003_bib66","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/cpt1978236669","article-title":"Gastrointestinal blood loss after diflunisal and after aspirin: Effect of ethanol","volume":"23","author":"DeSchepper","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib67","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/gut.12.10.819","article-title":"Aspirin and alcohol in gastrointestinal haemorrhage","volume":"12","author":"Needham","year":"1971","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2007.12.003_bib68","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/j.1572-0241.1999.01517.x","article-title":"The risk of acute major upper gastrointestinal bleeding among users of aspirin and ibuprofen at various levels of alcohol consumption","volume":"94","author":"Kaufman","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib69","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1047-2797(00)00040-5","article-title":"The effect of alcohol abuse on the risk of NSAID-related gastrointestinal events","volume":"10","author":"Neutel","year":"2000","journal-title":"Ann Epiderniol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib70_1","unstructured":"Celebrex (celecoxib) [prescribing information]"},{"key":"10.1016\/j.clinthera.2007.12.003_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000046212","article-title":"Renal effects of COX-2-selective inhibitors","volume":"21","author":"Brater","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib72","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0149-2918(04)90007-0","article-title":"Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials","volume":"26","author":"Curtis","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib73","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.1016\/0002-9343(91)90485-G","article-title":"Nonsteroidal anti-inflammatory drugs and antihypertensives","volume":"90","author":"Houston","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib74","doi-asserted-by":"crossref","first-page":"628","DOI":"10.7326\/0003-4819-107-5-628","article-title":"Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen","volume":"107","author":"Radack","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib75","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/106002809002400901","article-title":"Effect of naproxen and sulindac on blood pressure response to atenolol","volume":"24","author":"Abate","year":"1990","journal-title":"DICP"},{"key":"10.1016\/j.clinthera.2007.12.003_bib76","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archinte.153.4.477","article-title":"A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure","volume":"153","author":"Pope","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib77","first-page":"849","article-title":"NSAIDs, antihypertensive agents and loss of blood pressure control","volume":"51","author":"MacFarlane","year":"1995","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clinthera.2007.12.003_bib78","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/01.HYP.0000115921.55353.e0","article-title":"Effects of COX inhibition on blood pressure and kidney function in ACE inhibitor-treated blacks and Hispanics","volume":"43","author":"Izhar","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.clinthera.2007.12.003_bib79","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1592\/phco.23.14.1416.31935","article-title":"Comparison of changes in blood pressure measurements and antihypertensive therapy in older, hypertensive, ambulatory care patients prescribed celecoxib or rofecoxib","volume":"23","author":"Nietert","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2007.12.003_bib80","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/01.HYP.0000149684.01903.b8","article-title":"Treating osteoarthritis with cyclo-oxygenase-2-specific inhibitors: What are the benefits of avoiding blood pressure destabilization?","volume":"45","author":"Grover","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.clinthera.2007.12.003_bib81","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0002-9149(02)02661-9","article-title":"Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteo-arthritis","volume":"90","author":"Whelton","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib82","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.semarthrit.2003.12.003","article-title":"The use of methotrexate in rheumatoid arthritis","volume":"34","author":"Borchers","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2007.12.003_bib83","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0140-6736(86)90786-5","article-title":"Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen","volume":"1","author":"Thyss","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2007.12.003_bib84","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/106002809202600219","article-title":"Methotrexate and nonsteroidal antiinflammatory drug interactions","volume":"26","author":"Frenia","year":"1992","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2007.12.003_bib85","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/ard.62.5.423","article-title":"Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis","volume":"62","author":"Hoekstra","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clinthera.2007.12.003_bib86","first-page":"2539","article-title":"Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis","volume":"26","author":"Karim","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib87","first-page":"1008","article-title":"Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis","volume":"17","author":"Skeith","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib88","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/clpt.1990.69","article-title":"Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis","volume":"47","author":"Stewart","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib89","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/bmj.1.6171.1115","article-title":"Indomethacin increases plasma lithium","volume":"1","author":"Frolich","year":"1979","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2007.12.003_bib90","first-page":"161","article-title":"Ibuprofen can increase serum lithium level in lithium-treated patients","volume":"48","author":"Ragheb","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2007.12.003_bib91","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00004714-198606000-00005","article-title":"Lithium interaction with sulindac and naproxen","volume":"6","author":"Ragheb","year":"1986","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib92","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/bmj.302.6791.1537-b","article-title":"Lithium and non-steroidal anti-inflammatory drugs","volume":"302","author":"Khan","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2007.12.003_bib93","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.4088\/JCP.v64n1108","article-title":"Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs","volume":"64","author":"Phelan","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2007.12.003_bib94","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0009-9236(99)70056-1","article-title":"Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects","volume":"66","author":"Rossat","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib95","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archpsyc.1983.01790030053006","article-title":"Indomethacin but not aspirin increases plasma lithium ion levels","volume":"40","author":"Reimann","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2007.12.003_bib96","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/BF00613458","article-title":"Influence of intravenous acetylsalicylic acid and sodium salicylate on human renal function and lithium clearance","volume":"29","author":"Reimann","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib97","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00004714-199010000-00009","article-title":"The clinical significance of lithium-nonsteroidal antiinflammatory drug interactions","volume":"10","author":"Ragheb","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib98","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.amjmed.2005.03.044","article-title":"Selective serotonin reuptake inhibitors and increased bleeding risk: Are we missing something?","volume":"119","author":"Serebruany","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib99","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archinte.163.1.59","article-title":"Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: A population-based cohort study","volume":"163","author":"Dalton","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib100","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.319.7217.1106","article-title":"Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: Population based case-control study","volume":"319","author":"De Abajo","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2007.12.003_bib101","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1111\/j.1471-4159.1993.tb03522.x","article-title":"Primary structure of the human platelet serotonin uptake site: Identity with the brain serotonin transporter","volume":"60","author":"Lesch","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.clinthera.2007.12.003_bib102","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(94)90185-6","article-title":"Risks of bleeding peptic ulcer associated with individual nonsteroidal anti-inflammatory drugs","volume":"343","author":"Langman","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2007.12.003_bib103","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/bmj.331.7528.1310","article-title":"Risk of adverse gastrointestinal outcomes in patients taking cyclooxygenase-2 inhibitors or conventional non-steroidal antiinflammatory drugs: Population based nested case-control analysis","volume":"331","author":"Hippisley-Cox","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2007.12.003_bib104","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/bmj.323.7314.655","article-title":"Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: Retrospective cohort study","volume":"323","author":"van Walraven","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2007.12.003_bib105","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.0306-5251.2002.01770.x","article-title":"Combined use of SSRIs and NSAIDs increases the risk of gastrointestinal adverse effects","volume":"55","author":"de Jong","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib106","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2036.2005.02543.x","article-title":"Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal antiinflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?","volume":"22","author":"Tata","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib107","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00228-007-0263-y","article-title":"Risk of serious upper gastrointestinal events with concurrent use of NSAIDs and SSRIs: A case-control study in the general population","volume":"63","author":"Helin-Salmivaara","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib108_1","unstructured":"Flockhart DA. Cytochrome P450 drug interaction table"},{"key":"10.1016\/j.clinthera.2007.12.003_bib109","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.tips.2006.05.004","article-title":"Antidepressants and pain","volume":"27","author":"Mico","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.clinthera.2007.12.003_bib110","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1345\/aph.1G733","article-title":"Does celecoxib potentiate the anticoagulant effect of warfarin? A randomized, double-blind, controlled trial","volume":"40","author":"Dentali","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2007.12.003_bib111","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2125.2005.02322.x","article-title":"Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects","volume":"59","author":"Jiang","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib112","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/pmj.2003.006478","article-title":"Warfarin and celecoxib interaction in the setting of cytochrome P450 (CYP2C9) polymorphism with bleeding complication","volume":"80","author":"Malhi","year":"2004","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.clinthera.2007.12.003_bib113","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1002\/jps.20733","article-title":"Prediction of plasma protein binding displacement and its implications for quantitative assessment of metabolic drug-drug interactions from in vitro data","volume":"95","author":"Christensen","year":"2006","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.clinthera.2007.12.003_bib114","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2165\/00002018-200528070-00004","article-title":"Drug interactions of clinical importance with antihyperglycemic agents","volume":"28","author":"Scheen","year":"2005","journal-title":"Drug Sag"},{"key":"10.1016\/j.clinthera.2007.12.003_bib115","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/archinte.153.14.1665","article-title":"Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk for hemorrhagic peptic ulcer disease","volume":"153","author":"Shorr","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib116","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2710.2005.00676.x","article-title":"Bleeding complications in patients on celecoxib and warfarin","volume":"30","author":"Chung","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib117","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/009127002401102858","article-title":"Celecoxib does not affect the antiplatelet activity of aspirin in healthy volu nteers","volume":"42","author":"Wilner","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib118","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archinte.165.2.189","article-title":"Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors","volume":"165","author":"Battistella","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib119","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","article-title":"Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update","volume":"43","author":"Altman","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2007.12.003_bib120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1592\/phco.23.1.109.31913","article-title":"Warfarin and acetaminophen interaction","volume":"23","author":"Gebauer","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2007.12.003_bib121","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2125.2004.02199.x","article-title":"Paracetamol: A haemorrhagic risk factor in patients on warfarin","volume":"59","author":"Mahe","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib122","first-page":"1621","article-title":"Interaction between paracetamol and warfarin in patients: A double-blind, placebo-controlled, randomized study","volume":"91","author":"Mahe","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.clinthera.2007.12.003_bib123","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1592\/phco.27.5.675","article-title":"The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy","volume":"27","author":"Parra","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2007.12.003_bib124","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/106002809703100523","article-title":"Potential interaction between tramadol and warfarin","volume":"31","author":"Scher","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2007.12.003_bib125","first-page":"871","article-title":"Tramadol-warfarin interaction","volume":"18","author":"Sabbe","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2007.12.003_bib126","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.321.7270.1183","article-title":"Risk of gastrointestinal haemorrhage with long term use of aspirin: Meta-analysis","volume":"321","author":"Derry","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2007.12.003_bib127","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.amjcard.2005.01.049","article-title":"Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials","volume":"95","author":"Serebruany","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib128","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1046\/j.1365-2125.2003.01774.x","article-title":"Aspirin for the prevention of cardiovascular disease: Calculating benefit and harm in the individual patient","volume":"55","author":"Loke","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib129","first-page":"111","article-title":"Cyclooxygenase-2 specific inhibitors and upper gastrointestinal tolerability in patients with osteoarthritis receiving concomitant low dose aspirin: Pooled analysis of 2 trials","volume":"32","author":"Goldstein","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib130","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1136\/bmj.310.6983.827","article-title":"Prophylactic aspirin and risk of peptic ulcer bleeding","volume":"310","author":"Weil","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2007.12.003_bib131","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(04)16893-1","article-title":"Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: Randomised controlled trial","volume":"364","author":"Schnitzer","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2007.12.003_bib132","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa003199","article-title":"Cyclooxygenase inhibitors and the antiplatelet effects of aspirin","volume":"345","author":"Catella-Lawson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib133","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0002-9149(99)00324-0","article-title":"Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution","volume":"84","author":"Feldman","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib134","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V69.1.180.180","article-title":"Inhibition of thromboxane formation in vivo and ex vivo: Implications for therapy with platelet inhibitory drugs","volume":"69","author":"Reilly","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2007.12.003_bib135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clinthera.2005.01.011","article-title":"Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers","volume":"27","author":"Cryer","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib136","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(03)12509-3","article-title":"Effect of ibuprofen on cardioprotective effect of aspirin","volume":"361","author":"MacDonald","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2007.12.003_bib137","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians' Health Study","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib138","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/01.CIR.0000087593.07533.9B","article-title":"Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs","volume":"108","author":"Kurth","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2007.12.003_bib139","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jacc.2003.08.064","article-title":"The effects of nonelective non-aspirin non-steroidal antiinflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin","volume":"43","author":"Kimmel","year":"2004","journal-title":"J Am Coil Cardiol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archinte.141.3.293","article-title":"Aspirin and acetaminophen as constituents of analgesic combinations","volume":"141","author":"Beaver","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib141","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0030-4220(80)90430-2","article-title":"Evaluation ofoxycodone and acetaminophen in treatment of postoperative dental pain","volume":"50","author":"Cooper","year":"1980","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"Suppl 28","key":"10.1016\/j.clinthera.2007.12.003_bib142","first-page":"19","article-title":"Meta-analysis of single dose oral tramadol plus acetaminophen in acute postoperative pain","volume":"20","author":"McQuay","year":"2003","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib143","article-title":"Single dose dextropropoxyphene, alone and with paracetamol (acetaminophen), for post-operative pain","volume":"3","author":"Collins","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2007.12.003_bib144","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0304-3959(96)03319-2","article-title":"Paracetamol with and without codeine in acute pain: A quantitative systematic review","volume":"70","author":"Moore","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2007.12.003_bib145","first-page":"227","article-title":"Central nervous respiratory depressants-narcotic analgesics","volume":"3","author":"Borison","year":"1977","journal-title":"Pharmacol Ther [B]"},{"key":"10.1016\/j.clinthera.2007.12.003_bib146","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0014-2999(85)90628-4","article-title":"Involvement of different opioid receptor subtypes in electric shock-induced analgesia and motor suppression in the rat","volume":"114","author":"Nabeshima","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib147","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1520\/JFS2002309","article-title":"Postmortem oxycodone and hydrocodone blood concentrations","volume":"48","author":"Spiller","year":"2003","journal-title":"J Forensic Sci"},{"key":"10.1016\/j.clinthera.2007.12.003_bib148","first-page":"941","article-title":"Possible dangerous interaction of oxycontin and carisoprodol","volume":"67","author":"Reeves","year":"2003","journal-title":"Am Faro Physician"},{"key":"10.1016\/j.clinthera.2007.12.003_bib149","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00000433-199612000-00011","article-title":"Involvement of codeine in drug-related deaths","volume":"17","author":"Gerostamoulos","year":"1996","journal-title":"Am J Forensic Med Pathol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-2006-949149","article-title":"Review of deaths related to analgesic- and cough suppressantopioids; England and Wales 1996-2002","volume":"39","author":"Schifano","year":"2006","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.clinthera.2007.12.003_bib151","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/00007611-199808000-00004","article-title":"A review of carisoprodol deaths in Jefferson County, Alabama","volume":"91","author":"Davis","year":"1998","journal-title":"South Med J"},{"key":"10.1016\/j.clinthera.2007.12.003_bib152","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0379-0738(03)00100-2","article-title":"Fatal overdoses of tramadol: Is benzodiazepine a risk factor of lethality?","volume":"134","author":"Clarot","year":"2003","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.clinthera.2007.12.003_bib153","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0379-0738(99)00118-8","article-title":"Fatal overdose of tramadol and alprazolam","volume":"105","author":"Michaud","year":"1999","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.clinthera.2007.12.003_bib154","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00280101","article-title":"Impact of environmental and genetic factors on codeine analgesia","volume":"41","author":"Desmeules","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib155","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1213\/01.ane.0000189613.61910.32","article-title":"The analgesic effect oftramadol after intravenous injection in healthy volunteers in relation to CYP2D6","volume":"102","author":"Enggaard","year":"2006","journal-title":"Anesth Analg"},{"key":"10.1016\/j.clinthera.2007.12.003_bib156","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/00003495-199346020-00008","article-title":"Tramadol: A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states","volume":"46","author":"Lee","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2007.12.003_bib157","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0304-3959(03)00212-4","article-title":"Impact oFCYP2D6 genotype on postoperative tramadol analgesia","volume":"105","author":"Stamer","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.clinthera.2007.12.003_bib158","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jpeds.2007.01.049","article-title":"The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis","volume":"150","author":"Brousseau","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinthera.2007.12.003_bib159","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2125.2003.02002.x","article-title":"CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes","volume":"57","author":"Hutchinson","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib160","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/jat\/26.7.438","article-title":"Pharmacogenomics as molecular autopsy for postmortem forensic toxicology: Genotyping cytochrome P450 2D6 for oxycodone cases","volume":"26","author":"Jannetto","year":"2002","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib161","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/jpet.102.047779","article-title":"Pharmacokinetic\/pharmacodynamic modeling of the antinociceptive effects of (+)-tramadol in the rat: Role ofcytochrome P450 2D activity","volume":"305","author":"Garrido","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib162","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF00265920","article-title":"The effect of quinidine on the analgesic effect of codeine","volume":"42","author":"Sindrup","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib163","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1365-2125.1992.tb04134.x","article-title":"The effect of selective sero- tonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes","volume":"34","author":"Crewe","year":"1992","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib164","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.clpt.2004.11.002","article-title":"Paroxetine, a cytochrome P450 2D6 inhibitor, diminishes the stereoselective O-demethylation and reduces the hypoalgesic effect of tramadol","volume":"77","author":"Laugesen","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2007.12.003_bib165","first-page":"192","article-title":"Severe serotonin toxicity and manic switch induced by combined use of tramadol and paroxetine","volume":"41","author":"John","year":"2007","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.clinthera.2007.12.003_bib166","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/(SICI)1099-1166(199805)13:5<343::AID-GPS771>3.0.CO;2-5","article-title":"Serotonin syndrome following the administration of tramadol with paroxetine","volume":"13","author":"Lantz","year":"1998","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.clinthera.2007.12.003_bib167","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00004850-199705000-00010","article-title":"Serotonin syndrome attributed to tramadol addition to paroxetine therapy","volume":"12","author":"Egberts","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib168","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/106002809703100208","article-title":"Possible serotonin syndrome associated with tramadol and sertraline coadministration","volume":"31","author":"Mason","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2007.12.003_bib169","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00004714-200208000-00022","article-title":"Serotonin syndrome as a result of fluoxetine in a patient with tramadol abuse: Plasma level-correlated symptomatology","volume":"22","author":"Lange-Asschenfeldt","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2007.12.003_bib170","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/014107689909200915","article-title":"Serotonin syndrome with fluoxetine plus tramadol","volume":"92","author":"Kesavan","year":"1999","journal-title":"J R Soc Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib171","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0736-4679(95)02002-0","article-title":"Meperidine: Therapeutic use and toxicity","volume":"13","author":"Clark","year":"1995","journal-title":"J Emerg Med"},{"key":"10.1016\/j.clinthera.2007.12.003_bib172","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1136\/bmj.2.5321.1752-a","article-title":"Dangers of monoamine oxidase inhibitors","volume":"2","author":"Denton","year":"1962","journal-title":"Br Med J"},{"key":"10.1016\/j.clinthera.2007.12.003_bib173","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0140-6736(91)92219-R","article-title":"Severe adverse interaction between pethidine and selegiline","volume":"337","author":"Zornberg","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2007.12.003_bib174","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/bja\/aei210","article-title":"Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity","volume":"95","author":"Gillman","year":"2005","journal-title":"Br J Anaesth"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807003712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807003712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T14:06:13Z","timestamp":1684159573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291807003712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":174,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0149291807003712"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2007.12.003","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}